25 related articles for article (PubMed ID: 10021922)
1. An overview on the antileukemic potential of D-homo-aza- and respective 17beta-acetamido-steroidal alkylating esters.
Camoutsis C; Trafalis DT
Invest New Drugs; 2003 Feb; 21(1):47-54. PubMed ID: 12795529
[TBL] [Abstract][Full Text] [Related]
2. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
[TBL] [Abstract][Full Text] [Related]
3. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
Wang S; Liu M; Lewin NE; Lorenzo PS; Bhattacharrya D; Qiao L; Kozikowski AP; Blumberg PM
J Med Chem; 1999 Sep; 42(18):3436-46. PubMed ID: 10479277
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.
Pak Y; Enyedy IJ; Varady J; Kung JW; Lorenzo PS; Blumberg PM; Wang S
J Med Chem; 2001 May; 44(11):1690-701. PubMed ID: 11356104
[TBL] [Abstract][Full Text] [Related]
5. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 7,8-disubstituted benzolactam-V8 and its binding to protein kinase C.
Ma D; Zhang T; Wang G; Kozikowski AP; Lewin NE; Blumberg PM
Bioorg Med Chem Lett; 2001 Jan; 11(2):99-101. PubMed ID: 11206480
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.
Endo Y; Shimazu M; Fukasawa H; Driedger PE; Kimura K; Tomioka N; Itai A; Shudo K
Bioorg Med Chem Lett; 1999 Jan; 9(2):173-8. PubMed ID: 10021922
[TBL] [Abstract][Full Text] [Related]
8. [The active conformation of teleocidins: design and synthesis of new active molecules].
Endo Y; Ohno M; Shudo K
Yakugaku Zasshi; 1994 Jul; 114(7):464-77. PubMed ID: 7932093
[TBL] [Abstract][Full Text] [Related]
9. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
[TBL] [Abstract][Full Text] [Related]
10. Functions, Structures, and Engineering of the Teleocidin Biosynthetic Enzymes.
Mori T
Chem Pharm Bull (Tokyo); 2023; 71(3):188-197. PubMed ID: 36858523
[TBL] [Abstract][Full Text] [Related]
11. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Chem Rec; 2005; 5(4):185-95. PubMed ID: 16041745
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
Morita I; Mori T; Abe I
Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
